According to the report by Expert Market Research (EMR), the global lyme disease diagnostics market size reached a value of approximately USD 2.67 billion in 2023. Aided by the escalating prevalence of Lyme disease worldwide and the emerging innovations in diagnostic technologies, the market is projected to further grow at a CAGR of 6.86% between 2024 and 2032 to reach a value of USD 5.87 billion by 2032.
Lyme disease is an infectious disorder caused by the bacterium Borrelia burgdorferi, transmitted through the bite of infected black-legged ticks. This disease, if left undiagnosed or untreated, can spread to joints, heart, and nervous system, leading to serious health problems. Diagnostic tools for Lyme disease, such as serological tests, PCR testing, and Next-Generation Sequencing (NGS), are crucial for timely identification and appropriate treatment of the disease.
Get a Free Sample Report with Table of Contents – https://www.expertmarketresearch.com/reports/lyme-disease-diagnostics-market/requestsample
The global lyme disease diagnostics market growth is largely driven by the increasing incidence of Lyme disease worldwide. Environmental factors such as global warming, which extends the geographical range of ticks, and urbanisation, which leads to increased human-tick interactions, contribute significantly to this increase in incidence. This rising prevalence necessitates efficient diagnostic tools, thereby driving the growth of the Lyme disease diagnostics market.
Moreover, advancements in diagnostic technologies play a significant role in propelling the lyme disease diagnostics market development. Traditional diagnostic methods for Lyme disease often result in false negatives due to their inability to detect the disease in its early stages. However, recent advancements, such as the development of PCR testing and NGS, offer greater accuracy and faster results, making them highly beneficial for early detection and treatment.
In addition to the technological advancements, the growing awareness about Lyme disease is also fuelling the lyme disease diagnostics market expansion. Numerous health organisations and government bodies worldwide are conducting awareness campaigns about the disease and the importance of early detection, leading to increased usage of diagnostic tests.
Get a full report with table of content – https://www.expertmarketresearch.com/reports/lyme-disease-diagnostics-market
Furthermore, the rising demand for point-of-care (POC) testing in Lyme disease diagnosis is stimulating market expansion. POC tests provide rapid, on-site diagnosis, which is crucial for timely treatment of Lyme disease. The integration of POC testing into clinical practice is becoming increasingly common, driven by the need for faster diagnostics and subsequent treatment initiation, thus increasing the lyme disease diagnostics market demand.
Lyme Disease Diagnostics Market Segmentation
The market can be divided based on diagnostic technology, end user, and region.
Market Breakup by Diagnostic Technology
• Serological Test
• ELISA
• Western Blot
• Lymphocytic Transformation Test
• Urine Antigen Testing
• Immunofluorescent Staining
• Nucleic Acid Test
Market Breakup by End User
• Hospitals
• Clinical Laboratories
• Other End-Users
Market Breakup by Region
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa
Competitive Landscape
The EMR report looks into the market shares, plant turnarounds, capacities, investments, and acquisitions and mergers, among other major developments, of the global lyme disease diagnostics companies. Some of the major key players explored in the report by Expert Market Research are as follows:
• Abbott Laboratories
• Bio-Rad Laboratories
• Covance Inc.
• Fres F. Hoffmann-La Roche AG
• T2 Biosystems
• Oxford Immunotec
• Baxter
• Fresenius Medical Care
• Bolder Biotechnology, Inc.
• Roche Holding AG
• Siemens AG
• Immunetics Inc
• GlaxoSmithKline Pharmaceuticals
• Canon Lifesciences
• Covance
About Us
Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.
Our high-quality, data-driven analyses provide the essential framework for organisations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organisation remains agile, proactive, and poised for success in today’s competitive market.
Don’t miss the opportunity to elevate your business intelligence and fortify your strategic planning. Secure your organisation’s future success by acquiring one of our Expert Market Research reports today.
Media Contact:
Company Name: Claight Corporation
Contact Person: Kevin Jonathan, Business Consultant
Email: sales@expertmarketresearch.com
Toll Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com
